官方服务：
资源简介：
CAR-T therapy drugs
嵌合抗原受体T细胞（CAR-T）疗法药物
应用场景：
创建时间：
2024-06-09
相关数据集
αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors
This is a single arm, open-label, dose escalation clinical study to evaluate the safety and tolerability of autologous mesothelin (MSLN)-targeted chimeric antigen receptor (MSLN-CAR) T cells secreting
NIAID Data Ecosystem170
Dasatinib enhances anti-tumor efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion
CD19-targeted Chimeric antigen receptor T cells (CART) cells have shown remarkable promise in various B cell malignancies. Sustained tonic signaling and antigen exposure drives CART cell differentiati
NIAID Data Ecosystem120
An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other Cancers
Neuroblastoma is the commonest extra cranial solid cancer of childhood. Despite escalation of treatment regimens, a significant minority of patients die of their disease. Disialoganglioside (GD2) is c
NIAID Data Ecosystem100
Traditional Medicines Guide
The Traditional Medicines Guide is a detailed operational document outlining policies, procedures, and protocols involved in the gathering, preparation, and distribution of Indigenous traditional medi
DataCite Commons2025-11-20 更新140
Additional file 6 of Contextual reprogramming of CAR-T cells for treatment of HER2+ cancers
Additional file 6: Table S1. P values related to Fig. 2. Table S2. P values related to Fig. 3. Table S3. P values related to Fig. 4. Table S4. P values related to Fig. 5. Table S5. P values related to
NIAID Data Ecosystem110
